- Human Genome adopts rights plan to ward off Glaxo(Reuters) - Human Genome Sciences Inc said on Thursday it adopted a stockholder rights plan as the biotechnology company defends itself against a $2.6 billion hostile takeover bid by drugmaker GlaxoSmithKline Plc. Human Genome said its board deter... […]
- Experimental Drug Helps Fight Some Childhood Cancers, Study
FindsWEDNESDAY, May 16 (HealthDay News) -- A new targeted drug therapy may help treat certain advanced cancers in children, a new preliminary study indicates. […]
Subscribe to this site's RSS feed.